Fresenius Medical Care AG ADR(FMS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 11.7 | EPS (ttm) | 1.94 | Insider Own | - | Shs Outstand | 532.2M | Perf Week | 2.3% |
| Market Cap | 12.07B | Forward P/E | 9.4 | EPS next Y | 4.72% | Insider Trans | - | Shs Float | 532.2M | Perf Month | 1.48% |
| Enterprise Value | 24.51B | PEG | 2.95 | EPS next Q | 0.65 | Inst Own | 7.93% | Short Float | 0.53% | Perf Quarter | -8.81% |
| Income | 1.09B | P/S | 0.53 | EPS this Y | -8.56% | Inst Trans | 0.29% | Short Ratio | 3.12 | Perf Half Y | -0.4% |
| Sales | 22.66B | P/B | 0.84 | EPS next 5Y | 3.19% | ROA | 3.02% | Short Interest | 2.83M | Perf YTD | -4.79% |
| Book/sh | 26.97 | P/C | 9.95 | EPS past 3/5Y | 16.25% -3.43% | ROE | 7.3% | 52W High | -17.23% ($27.40) | Perf Year | -15.75% |
| Cash/sh | 2.28 | P/FCF | 5.77 | Sales past 3/5Y | 2.83% 1.71% | ROIC | 4.51% | 52W Low | 13.29% ($20.02) | Perf 3Y | 30.8% |
| Dividend Est. | $0.82 (3.62%) | EV/EBITDA | 5.9 | EPS Y/Y TTM | 57.96% | Gross Margin | 26.36% | Volatility(W/M) | 2.76% 2.26% | Perf 5Y | -36.33% |
| Dividend TTM | 0.86 | EV/Sales | 1.08 | Sales Y/Y TTM | 6.76% | Oper. Margin | 10.9% | ATR (14) | 0.53 | Perf 10Y | -45.32% |
| Dividend Ex-Date | 2026/5/22 | Quick Ratio | 0.75 | EPS Q/Q | 8.69% | Profit Margin | 4.82% | RSI (14) | 56.93 | Recom | 4 |
| Dividend Gr. 3/5Y | 13.25% 1.37% | Current Ratio | 1.07 | Sales Q/Q | 4.06% | SMA20 | 3.62% ($21.89) | Beta | 0.76 | Target Price | $21.25 |
| Payout | 31.98% | Debt/Eq | 0.87 | Earnings | 2026/8/3 | SMA50 | 0.89% ($22.48) | Rel Volume | 0.81 | Prev Close | $22.23 |
| Employees | 111024 | LT Debt/Eq | 0.69 | EPS/Sales Surpr. | 5.07% 2.22% | SMA200 | -0.86% ($22.88) | Avg Volume(3M) | 0.91M | Price | $22.68 |
| IPO | 1996/9/17 | Option/Short | Yes/Yes | Trades | 4545 | Volume | 733,482 | Change | 2.02% |
A German healthcare company and a global dialysis specialist that provides kidney dialysis treatment services along with dialysis equipment and supplies. It is listed on the US stock exchange as an ADR, with its performance driven by the number of dialysis patients and healthcare cost policies.
Over the past 1 year, roughly in the middle
17% below its 1-year high.
Traded about as much as usual. That is 81% of its average volume.
FMS earns at a steady pace
Of every $100 in sales, $10.90 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -8.6% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company expected to earn $100 next year, you would pay $940. Peers typically go for $1,832.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Sell.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -36.3%. The S&P 500 did +68% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 3.62% annually in dividends.
Tap to view numbers
Institutions barely hold it
Institutions hold 7.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #4 of 48 in the industry
Based on market cap of $12B.
EHC#3 Encompass Health Corp $12B PER 20.2 FMS#4 Fresenius Medical Care AG ADR $12B PER 11.7 
DVA#5 DaVita Inc $12B PER 15.5 
UHS#6 Universal Health Services Inc $11B PER 7.6 
ENSG#7 Ensign Group Inc $10B PER 27.5 
FAQ
What kind of company is FMS?
FMS belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of FMS?
The market cap of FMS is approximately $12.1B, ranking 814 within its sector.
Does FMS pay dividends?
FMS has a dividend yield of approximately 3.62%, with an annual dividend of $0.82.
What is the P/E ratio of FMS?
FMS has a P/E ratio of approximately 11.7x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for FMS?
FMS has recorded a 52-week high of $27.40 and a low of $20.02.
